Evidence map›Paper›PMID 26961153›Full record

ArticleScientific reports2016

Insight into determinants of substrate binding and transport in a multidrug efflux protein.

Kamela O Alegre, Stephanie Paul, Paola Labarbuta, Christopher J Law

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. A major facilitator superfamily transporter MdtH inApplied and environmental microbiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kamela O AlegreSchool of Biological Sciences, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
Stephanie PaulSchool of Biological Sciences, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
Paola LabarbutaSchool of Biological Sciences, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
Christopher J LawSchool of Biological Sciences, Medical Biology Centre, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
Queen's University Belfast · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K014226/1
6 · The paper itself

Abstract

Multidrug resistance arising from the activity of integral membrane transporter proteins presents a global public health threat. In bacteria such as Escherichia coli, transporter proteins belonging to the major facilitator superfamily make a considerable contribution to multidrug resistance by catalysing efflux of myriad structurally and chemically different antimicrobial compounds. Despite their clinical relevance, questions pertaining to mechanistic details of how these promiscuous proteins function remain outstanding, and the role(s) played by individual amino acid residues in recognition, binding and subsequent transport of different antimicrobial substrates by multidrug efflux members of the major facilitator superfamily requires illumination. Using in silico homology modelling, molecular docking and mutagenesis studies in combination with substrate binding and transport assays, we identified several amino acid residues that play important roles in antimicrobial substrate recognition, binding and transport by Escherichia coli MdtM, a representative multidrug efflux protein of the major facilitator superfamily. Furthermore, our studies suggested that 'aromatic clamps' formed by tyrosine and phenylalanine residues located within the substrate binding pocket of MdtM may be important for antimicrobial substrate recognition and transport by the protein. Such 'clamps' may be a structurally and functionally important feature of all major facilitator multidrug efflux proteins.

Indexed as

Drug Resistance, Multiple, BacterialAmino AcidsAnti-Bacterial AgentsAntiportersBiological TransportChloramphenicolComputer SimulationEscherichia coliEscherichia coli ProteinsMolecular Docking SimulationMutagenesis, Site-DirectedMutationOnium CompoundsOrganophosphorus CompoundsProtein BindingProtein ConformationAmino AcidsAnti-Bacterial AgentsAntiportersChloramphenicolEscherichia coli ProteinsMdtM protein, E coliOnium CompoundsOrganophosphorus Compoundstetraphenylphosphonium

Identifiers

PMID26961153
PMCPMC4785361
OpenAlexW2295548769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.